Viatris (VTRS) Shareholder's Equity (2018 - 2026)

Viatris (VTRS) Shareholder's Equity (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 8.23 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 3.23 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 5.90 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 407.18 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 3.41 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 6.50 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 1.75 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 446.17 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 1.21 Bn
10 Viatris - - 1.16 Bn 14.66 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 14.66 Bn
Dec 31, 2025 14.71 Bn
Sep 30, 2025 15.22 Bn
Jun 30, 2025 15.57 Bn
Mar 31, 2025 15.65 Bn
Dec 31, 2024 18.64 Bn
Sep 30, 2024 19.79 Bn
Jun 30, 2024 19.52 Bn
Mar 31, 2024 20.01 Bn
Dec 31, 2023 20.47 Bn
Sep 30, 2023 20.87 Bn
Jun 30, 2023 20.84 Bn
Mar 31, 2023 20.93 Bn
Dec 31, 2022 21.07 Bn
Sep 30, 2022 19.18 Bn
Jun 30, 2022 19.81 Bn
Mar 31, 2022 20.45 Bn
Dec 31, 2021 20.49 Bn
Sep 30, 2021 21.14 Bn
Jun 30, 2021 21.21 Bn